BSECompany Update2d ago · 23 Sept 2026, 02:25 pm

Please find attached herewith intimation of Schedule of Analyst / Institutional Investor Meeting.

Alkem Laboratories Ltd · 539523

✦ AI Summary

Alkem Laboratories Ltd has announced the schedule of an Analyst / Institutional Investor meeting to be held on 7th October 2026 at HDFC Mutual Fund in Mumbai.

Analysis Scores

Earnings Impact1/10

Growth Catalyst1/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk1/10

Liquidity Impact5/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

aa5139f2-4c25-4582-ab61-c75eee96c018.pdf

pdf

Download →

View document text

23rd September, 2026 The Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai 400 001. Mumbai 400 051. Scrip Code: 539523 Scrip Symbol: ALKEM Sub: Intimation of Schedule of Analyst / Institutional Investor Meeting Dear Sir(s)/ Madam, With reference to relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of Analyst / Institutional Investor meeting to be conducted are as follow: Type of Nature of Date Analyst / Investor Location Meeting Meeting 07th October, In-person One- on- Mumbai HDFC Mutual Fund 2026 One meet The schedule of the abovementioned meeting is subject to change due to exigencies on the part of the Investor / Company. Kindly take note of the same. Sincerely, For Alkem Laboratories Limited Divya Mewani Vice President – Legal & Deputy Company Secretary